Ambey Laboratories IPO vs Nephro Care India IPO

Comparision between Ambey Laboratories IPO and Nephro Care India IPO.

IPO Details

Ambey Laboratories IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.

	Ambey Laboratories IPO	Nephro Care India IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	NSE SME	NSE SME
Lead Managers	Fast Track Finsec Pvt Ltd	Corporate Capitalventures Pvt Ltd
Registrar	Link Intime India Private Ltd	Bigshare Services Pvt Ltd
Market Maker	Nikunj Stock Brokers Limited	Ss Corporate Securities Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Ambey Laboratories IPO is ₹68.00 per share and of Nephro Care India IPO is ₹90.00 per share.

	Ambey Laboratories IPO	Nephro Care India IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹65.00 per share	₹85.00 per share
Issue Price (Upper)	₹68.00 per share	₹90.00 per share
Issue Price (Final)	₹68.00 per share	₹90.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	1600 shares
Fresh Issue Size	62,58,000 shares	45,84,000 shares
Fresh Issue Size (Amount)	up to ₹42.55 Cr	up to ₹41.26 Cr
OFS Issue Size	3,12,000 shares
OFS Issue Size (Amount)	up to ₹2.12 Cr
Issue Size Total	65,70,000 shares	45,84,000 shares
Issue Size Total (Amount)	up to ₹44.68 Cr	up to ₹41.26 Cr

IPO Timetable

Ambey Laboratories IPO opens on Jul 04, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Ambey Laboratories IPO and Nephro Care India IPO is Jul 08, 2024, and Jul 02, 2024, respectively.

	Ambey Laboratories IPO	Nephro Care India IPO
Anchor Bid Date	Jul 03, 2024	Jun 27, 2024
Issue Open	Jul 04, 2024	Jun 28, 2024
Issue Close	Jul 08, 2024	Jul 02, 2024
Basis Of Allotment (Tentative)	Jul 09, 2024	Jul 03, 2024
Initiation of Refunds (Tentative)	Jul 10, 2024	Jul 04, 2024
Credit of Share (Tentative)	Jul 10, 2024	Jul 04, 2024
Listing date (Tentative)	Jul 11, 2024	Jul 05, 2024
Anchor Lockin End date 1	Aug 08, 2024	Aug 02, 2024
Anchor Lockin End date 2	Oct 07, 2024	Oct 01, 2024

Financials

Ambey Laboratories IPO P/E ratio is 27.81, as compared to Nephro Care India IPO P/E ratio of 55.15.

Ambey Laboratories IPO

Nephro Care India IPO

Financial

Ambey Laboratories Limited Financial Information (Restated)

Period Ended	31 Jan 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	8,620.84	5,761.85	5,592.94	4,461.80
Revenue	10,043.69	10,743.47	8,511.19	8,241.54
Profit After Tax	607.73	456.93	357.47	1,033.67
Net Worth	3,431.34	2,363.60	1,906.67	-786.39
Reserves and Surplus	1,562.46	588.66	131.73	-1,275.74
Total Borrowing	2,005.44	1,365.22	1,804.86	3,292.98
Amount in ₹ Lakhs

Nephro Care India Limited Financial Information (Restated)

Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	2,029.85	831.11	462.93	112.84
Revenue	1,989.60	1,709.51	342.70	183.26
Profit After Tax	340.04	194.24	-0.98	8.87
Net Worth	1,392.32	243.76	49.52	1.50
Reserves and Surplus	1,332.81	193.76	-0.48	0.50
Total Borrowing		246.39	253.74	69.27
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

94.97%

85.02%

Promoter Shareholding (Post-Issue)

69.90%

61.39%

P/E Ratio

27.81

55.15

Market Cap

₹171.64 Cr.

₹148.38 Cr.

ROE

20.80%%

41.57%%

ROCE

13.14%%

36.56%%

Debt/Equity

0.58

EPS

₹2.44

₹1.63

RoNW

20.80%%

24.42%%

Shares Offered

In the Ambey Laboratories IPO retail investors (RII) are offered 21,84,000 shares while in Nephro Care India IPO retail investors are offered 21,84,000 shares. Qualified institutional buyers (QIB) are offered 12,52,000 shares in Ambey Laboratories IPO and 8,25,600 shares in Nephro Care India IPO.

	Ambey Laboratories IPO	Nephro Care India IPO
Anchor Investor Reserveration	18,72,000 shares	12,38,400 shares
Market Maker Reserveration	3,30,000 shares	2,30,400 shares
QIB	12,52,000 shares	8,25,600 shares
NII	6,06,001 shares	6,19,200 shares
RII	21,84,000 shares	14,44,800 shares
Employee	0 shares	0 shares
Others
Total	40,42,001 shares	31,15,200 shares

Bids Received (Subscription)

Ambey Laboratories IPO subscribed 173.18x in total, whereas Nephro Care India IPO subscribed 715.78x.

	Ambey Laboratories IPO	Nephro Care India IPO
QIB (times)	61.90x	245.14x
NII (times)	324.22x	1,787.19x
Big NII (times)
Small NII (times)
RII (times)	195.06x	634.12x
Employee (times)
Other (times)
Total (times)	173.18x	715.78x

Compare with others

Ambey Laboratories IPO	Nephro Care India IPO
Sati Poly Plast IPO	Sahaj Solar IPO
Sahaj Solar IPO	Aelea Commodities IPO
Aelea Commodities IPO	Ganesh Green Bharat IPO
Ganesh Green Bharat IPO	Effwa Infra and Research IPO
Effwa Infra and Research IPO	Ambey Laboratories IPO
Nephro Care India IPO	Diensten Tech IPO
Diensten Tech IPO	Visaman Global Sales IPO
Visaman Global Sales IPO	Mason Infratech IPO
Mason Infratech IPO	Petro Carbon and Chemicals IPO
Petro Carbon and Chemicals IPO	Sylvan Plyboard IPO

Comments

Add a public comment...